NDA 205986, held by Praxair Canada Inc. Oxygen.
As of Nov 14, 2026, NDA 205986 (Oxygen, Usp), held by Praxair Canada Inc, was first approved by FDA on Aug 27, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 27, 2013 | Original applicationMEDGAS · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oxygen, UspN/A · gas;inhalation | Oxygen | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
